4,944
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Topical cream delivers NB-UVB from sunlight for the treatment of vitiligo

, PhD, , PhD, , MD & , MD

Bibliography

  • Halder RM, Chappell JL. Vitiligo update. Semin Cutan Med Surg 2009;28(2):86-92
  • Karsli N, Akcali C, Ozgoztasi O, et al. Role of oxidative stress in the pathogenesis of vitiligo with special emphasis on the antioxidant action of narrowband ultraviolet B phototherapy. J Int Med Res 2014;42(3):799-805
  • Hossani-Madani A, Halder R. Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes. G Ital Dermatol Venereol 2011;146(5):373-95
  • Taieb A, Alomar A, Bohm M, et al. Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol 2013;168(1):5-19
  • Grimes PE, Morris R, Avaniss-Aghajani E, et al. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 2004;51(1):52-61
  • Shi F, Erf GF. IFN-gamma, IL-21, and IL-10 co-expression in evolving autoimmune vitiligo lesions of Smyth line chickens. J Invest Dermatol 2012;132(3 Pt 1):642-9
  • Ring J, Mohrenschlager M, Henkel V. The US FDA ’black box’ warning for topical calcineurin inhibitors: an ongoing controversy. Drug Saf 2008;31(3):185-98
  • Korobko IV. Review of current clinical studies of vitiligo treatments. Dermatol Ther 2012;25(Suppl 1):S17-27
  • Mulekar SV, Isedeh P. Surgical interventions for vitiligo: an evidence-based review. Br J Dermatol 2013;169(Suppl 3):57-66
  • Verma R, Grewal RS, Chatterjee M, et al. A comparative study of efficacy of cultured versus non cultured melanocyte transfer in the management of stable vitiligo. Med J Armed Forces India 2014;70(1):26-31
  • Alhowaish AK, Dietrich N, Onder M, Fritz K. Effectiveness of a 308-nm excimer laser in treatment of vitiligo: a review. Lasers Med Sci 2013;28(3):1035-41
  • Park KK, Liao W, Murase JE. A review of monochromatic excimer light in vitiligo. Br J Dermatol 2012;167(3):468-78
  • Bhatnagar A, Kanwar AJ, Parsad D, De D. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study. J Eur Acad Dermatol Venereol 2007;21(5):638-42
  • Yones SS, Palmer RA, Garibaldinos TM, Hawk JL. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy. Arch Dermatol 2007;143(5):578-84
  • Nicolaidou E, Antoniou C, Stratigos A, Katsambas AD. Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review. J Am Acad Dermatol 2009;60(3):470-7
  • Brazzelli V, Antoninetti M, Palazzini S, et al. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy. J Eur Acad Dermatol Venereol 2007;21(10):1369-74
  • Brazzelli V, Prestinari F, Castello M, et al. Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm). Pediatr Dermatol 2005;22(3):257-61
  • Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol 1995;105(1):32-7
  • Wu CS, Yu CL, Wu CS, et al. Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes. Exp Dermatol 2004;13(12):755-63
  • Rokos H, Beazley WD, Schallreuter KU. Oxidative stress in vitiligo: photo-oxidation of pterins produces H(2)O(2) and pterin-6-carboxylic acid. Biochem Biophys Res Commun 2002;292(4):805-11
  • Yazdani Abyaneh M, Griffith RD, Falto-Aizpurua L, Nouri K. Narrowband ultraviolet B phototherapy in combination with other therapies for vitiligo: mechanisms and efficacies. J Eur Acad Dermatol Venereol 2014. doi: 10.1111/jdv.12619
  • Haykal KA, DesGroseilliers JP. Are narrow-band ultraviolet B home units a viable option for continuous or maintenance therapy of photoresponsive diseases? J Cutan Med Surg 2006;10(5):234-40
  • Cameron H, Yule S, Moseley H, et al. Taking treatment to the patient: development of a home TL-01 ultraviolet B phototherapy service. Br J Dermatol 2002;147(5):957-65
  • Kudish AI, Abels D, Harari M. Ultraviolet radiation properties as applied to photoclimatherapy at the Dead Sea. Int J Dermatol 2003;42(5):359-65
  • Harari M, Novack L, Barth J, et al. The percentage of patients achieving PASI 75 after 1 month and remission time after climatotherapy at the Dead Sea. Int J Dermatol 2007;46(10):1087-91
  • Harari M, Shani J. Demographic evaluation of successful antipsoriatic climatotherapy at the Dead Sea (Israel) DMZ Clinic. Int J Dermatol 1997;36(4):304-8
  • Czarnowicki T, Harari M, Ruzicka T, Ingber A. Dead Sea climatotherapy for vitiligo: a retrospective study of 436 patients. J Eur Acad Dermatol Venereol 2011;25(8):959-63
  • McCoy J, Goren A, Lotti T. In vitro evaluation of a novel topical cream for vitiligo and psoriasis that selectively delivers NB-UVB therapy when exposed to sunlight. Dermatol Ther 2014;27(2):117-20
  • Goren A, Salafia A, McCoy J, et al. Novel topical cream delivers safe and effective sunlight therapy for vitiligo by selectively filtering damaging ultraviolet radiation. Dermatol Ther 2014;27(4):195-7
  • Park K, Murase J. Ultraviolet B (UVB) phototherapy in the treatment of vitiligo. Vitiligo – Manag Ther 2011;179. ISBN: 978-953-307-731-4. Available from: http://www.intechopen.com/books/vitiligo-management-and-therapy/ultraviolet-b-uvb- phototherapy-in-the-treatment-of-vitiligo
  • Goren A, Salafia A, McCoy J, et al. Novel topical cream delivers safe and effective alternative to traditional psoriasis phototherapy. Dermatol Ther 2014;27(5):260-3
  • Nordal EJ, Guleng GE, Ronnevig JR. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study. Journal of the European Academy of Dermatology and Venereology : JEADV 2011;25(12):1440-3
  • Lee BW, Schwartz RA, Hercogova J, et al. Vitiligo road map. Dermatol Ther 2012;25(Suppl 1):S44-56
  • Lotti T, D’Erme AM. Vitiligo as a systemic disease. Clin Dermatol 2014;32(3):430-4
  • Lotti T, Zanardelli M, D’Erme AM. Vitiligo: what’s new in the psycho-neuro-endocrine-immune connection and related treatments. Wien Med Wochenschr 2014;164(13-14):278-85

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.